S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
OTCMKTS:CDMGF

Icade (CDMGF) Stock Price, News & Analysis

$27.00
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$27.00
$27.00
50-Day Range
$27.00
$37.00
52-Week Range
$27.00
$47.14
Volume
N/A
Average Volume
800 shs
Market Capitalization
N/A
P/E Ratio
22.10
Dividend Yield
13.59%
Price Target
N/A
CDMGF stock logo

About Icade Stock (OTCMKTS:CDMGF)

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth 6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of 1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a SIIC on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.

CDMGF Stock Price History

CDMGF Stock News Headlines

Icade: Poised To Outperform
Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Icad Rises on Google Health Development Deal
Icade (ICAD.PA)
Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Icad: Q4 Earnings Snapshot
Icad (ICAD) Reports Q3 Loss, Misses Revenue Estimates
Icad: Q3 Earnings Snapshot
Director Of Icad Makes $217.70 Thousand Sale
See More Headlines
Receive CDMGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
REIT - Diversified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CDMGF
CIK
N/A
Fax
N/A
Employees
1,124
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Nicolas Joly
    Chief Executive Officer
  • Ms. Victoire Aubry (Age 58)
    Head of Finance, IT & Work Environment
  • Ms. Sophie Duval
    Head of Consolidation & Accounting
  • Ms. Anne-Violette Faugeras
    Director of Financing & Investor Relations
  • Mr. Jérôme Lucchini (Age 57)
    General Secretary and Head of Governance, Legal Insurance & Department
  • Ms. Emmanuelle Baboulin (Age 58)
    Head of the Commercial Property Investment Division
  • Mr. Xavier de La Sudrie
    Head of Financial Control
  • Johannah Mrejen
    Head of Asset Management
  • Mr. Guillaume Tessler
    Head of International Development - Icade Santé
  • Mr. Henri Chapouthier
    Head of Sustainable Development

CDMGF Stock Analysis - Frequently Asked Questions

Should I buy or sell Icade stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Icade in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CDMGF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDMGF, but not buy additional shares or sell existing shares.
View CDMGF analyst ratings
or view top-rated stocks.

How have CDMGF shares performed in 2024?

Icade's stock was trading at $37.00 at the beginning of the year. Since then, CDMGF stock has decreased by 27.0% and is now trading at $27.00.
View the best growth stocks for 2024 here
.

Are investors shorting Icade?

Icade saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 269,700 shares, an increase of 5.5% from the January 31st total of 255,700 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 2,697.0 days.
View Icade's Short Interest
.

Is Icade a good dividend stock?

Icade (OTCMKTS:CDMGF) pays an annual dividend of $3.67 per share and currently has a dividend yield of 6.28%. CDMGF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 300.37%. Payout ratios above 75% are not desirable because they may not be sustainable.

How do I buy shares of Icade?

Shares of CDMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CDMGF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners